EUROFINS SCIENTIFIC (ESF0.DE) Fundamental Analysis & Valuation
FRA:ESF0 • FR0014000MR3
Current stock price
61.5 EUR
-1.26 (-2.01%)
Last:
This ESF0.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ESF0.DE Profitability Analysis
1.1 Basic Checks
- ESF0 had positive earnings in the past year.
- ESF0 had a positive operating cash flow in the past year.
- ESF0 had positive earnings in each of the past 5 years.
- Each year in the past 5 years ESF0 had a positive operating cash flow.
1.2 Ratios
- ESF0 has a Return On Assets (3.73%) which is in line with its industry peers.
- ESF0's Return On Equity of 9.02% is fine compared to the rest of the industry. ESF0 outperforms 66.67% of its industry peers.
- ESF0's Return On Invested Capital of 6.74% is fine compared to the rest of the industry. ESF0 outperforms 66.67% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for ESF0 is below the industry average of 9.34%.
- The last Return On Invested Capital (6.74%) for ESF0 is above the 3 year average (6.44%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.73% | ||
| ROE | 9.02% | ||
| ROIC | 6.74% |
ROA(3y)3.11%
ROA(5y)4.62%
ROE(3y)6.89%
ROE(5y)9.79%
ROIC(3y)6.44%
ROIC(5y)8.49%
1.3 Margins
- The Profit Margin of ESF0 (5.62%) is comparable to the rest of the industry.
- ESF0's Profit Margin has declined in the last couple of years.
- The Operating Margin of ESF0 (10.87%) is worse than 61.11% of its industry peers.
- In the last couple of years the Operating Margin of ESF0 has declined.
- ESF0 has a worse Gross Margin (21.39%) than 77.78% of its industry peers.
- In the last couple of years the Gross Margin of ESF0 has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.87% | ||
| PM (TTM) | 5.62% | ||
| GM | 21.4% |
OM growth 3Y-11.04%
OM growth 5Y-10.39%
PM growth 3Y-13.43%
PM growth 5Y-9.58%
GM growth 3Y-1.72%
GM growth 5Y-3.8%
2. ESF0.DE Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ESF0 is destroying value.
- ESF0 has less shares outstanding than it did 1 year ago.
- The number of shares outstanding for ESF0 has been reduced compared to 5 years ago.
- ESF0 has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 2.49 indicates that ESF0 is not a great score, but indicates only limited risk for bankruptcy at the moment.
- ESF0 has a Altman-Z score (2.49) which is in line with its industry peers.
- ESF0 has a debt to FCF ratio of 5.14. This is a neutral value as ESF0 would need 5.14 years to pay back of all of its debts.
- ESF0's Debt to FCF ratio of 5.14 is fine compared to the rest of the industry. ESF0 outperforms 72.22% of its industry peers.
- A Debt/Equity ratio of 0.82 indicates that ESF0 is somewhat dependend on debt financing.
- ESF0's Debt to Equity ratio of 0.82 is on the low side compared to the rest of the industry. ESF0 is outperformed by 61.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 5.14 | ||
| Altman-Z | 2.49 |
ROIC/WACC0.79
WACC8.5%
2.3 Liquidity
- ESF0 has a Current Ratio of 1.09. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
- With a Current ratio value of 1.09, ESF0 is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
- ESF0 has a Quick Ratio of 1.03. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.03, ESF0 is in line with its industry, outperforming 44.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.03 |
3. ESF0.DE Growth Analysis
3.1 Past
- ESF0 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.73%, which is quite good.
- Measured over the past years, ESF0 shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.09% on average per year.
- Looking at the last year, ESF0 shows a small growth in Revenue. The Revenue has grown by 4.96% in the last year.
- ESF0 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.05% yearly.
EPS 1Y (TTM)12.73%
EPS 3Y-8.95%
EPS 5Y-3.09%
EPS Q2Q%6.78%
Revenue 1Y (TTM)4.96%
Revenue growth 3Y2.82%
Revenue growth 5Y6.05%
Sales Q2Q%4.3%
3.2 Future
- ESF0 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.11% yearly.
- Based on estimates for the next years, ESF0 will show a small growth in Revenue. The Revenue will grow by 7.47% on average per year.
EPS Next Y8.32%
EPS Next 2Y11.81%
EPS Next 3Y13.96%
EPS Next 5Y16.11%
Revenue Next Year4.69%
Revenue Next 2Y5.62%
Revenue Next 3Y5.95%
Revenue Next 5Y7.47%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. ESF0.DE Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 16.53 indicates a correct valuation of ESF0.
- Compared to the rest of the industry, the Price/Earnings ratio of ESF0 indicates a somewhat cheap valuation: ESF0 is cheaper than 72.22% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 25.23, ESF0 is valued a bit cheaper.
- ESF0 is valuated correctly with a Price/Forward Earnings ratio of 15.76.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of ESF0 indicates a somewhat cheap valuation: ESF0 is cheaper than 72.22% of the companies listed in the same industry.
- ESF0's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.42.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.53 | ||
| Fwd PE | 15.76 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ESF0 indicates a somewhat cheap valuation: ESF0 is cheaper than 77.78% of the companies listed in the same industry.
- 94.44% of the companies in the same industry are more expensive than ESF0, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.99 | ||
| EV/EBITDA | 9.79 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- ESF0's earnings are expected to grow with 13.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.99
PEG (5Y)N/A
EPS Next 2Y11.81%
EPS Next 3Y13.96%
5. ESF0.DE Dividend Analysis
5.1 Amount
- ESF0 has a Yearly Dividend Yield of 1.16%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 0.56, ESF0 pays a better dividend. On top of this ESF0 pays more dividend than 88.89% of the companies listed in the same industry.
- ESF0's Dividend Yield is slightly below the S&P500 average, which is at 1.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.16% |
5.2 History
- The dividend of ESF0 is nicely growing with an annual growth rate of 16.09%!
Dividend Growth(5Y)16.09%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
- 26.80% of the earnings are spent on dividend by ESF0. This is a low number and sustainable payout ratio.
- ESF0's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP26.8%
EPS Next 2Y11.81%
EPS Next 3Y13.96%
ESF0.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:ESF0 (3/19/2026, 7:00:00 PM)
61.5
-1.26 (-2.01%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)01-29 2026-01-29/bmo
Earnings (Next)04-22 2026-04-22
Inst Owners33.9%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap11.20B
Revenue(TTM)7.30B
Net Income(TTM)409.70M
Analysts72
Price Target72.63 (18.1%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.16% |
Yearly Dividend0.6
Dividend Growth(5Y)16.09%
DP26.8%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.21%
PT rev (3m)10.35%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3.42%
EPS NY rev (3m)-1.72%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.98%
Revenue NY rev (3m)-0.9%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.53 | ||
| Fwd PE | 15.76 | ||
| P/S | 1.54 | ||
| P/FCF | 12.99 | ||
| P/OCF | 8.01 | ||
| P/B | 2.47 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.79 |
EPS(TTM)3.72
EY6.05%
EPS(NY)3.9
Fwd EY6.34%
FCF(TTM)4.73
FCFY7.7%
OCF(TTM)7.68
OCFY12.49%
SpS40.05
BVpS24.94
TBVpS-4.41
PEG (NY)1.99
PEG (5Y)N/A
Graham Number45.69
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.73% | ||
| ROE | 9.02% | ||
| ROCE | 9.27% | ||
| ROIC | 6.74% | ||
| ROICexc | 7.43% | ||
| ROICexgc | 23.86% | ||
| OM | 10.87% | ||
| PM (TTM) | 5.62% | ||
| GM | 21.4% | ||
| FCFM | 11.82% |
ROA(3y)3.11%
ROA(5y)4.62%
ROE(3y)6.89%
ROE(5y)9.79%
ROIC(3y)6.44%
ROIC(5y)8.49%
ROICexc(3y)7.17%
ROICexc(5y)9.25%
ROICexgc(3y)23.01%
ROICexgc(5y)30.49%
ROCE(3y)8.97%
ROCE(5y)11.81%
ROICexgc growth 3Y-10.94%
ROICexgc growth 5Y-13.82%
ROICexc growth 3Y-8.95%
ROICexc growth 5Y-10.36%
OM growth 3Y-11.04%
OM growth 5Y-10.39%
PM growth 3Y-13.43%
PM growth 5Y-9.58%
GM growth 3Y-1.72%
GM growth 5Y-3.8%
F-Score7
Asset Turnover0.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 5.14 | ||
| Debt/EBITDA | 2.44 | ||
| Cap/Depr | 74.23% | ||
| Cap/Sales | 7.35% | ||
| Interest Coverage | 6.87 | ||
| Cash Conversion | 92.26% | ||
| Profit Quality | 210.5% | ||
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z | 2.49 |
F-Score7
WACC8.5%
ROIC/WACC0.79
Cap/Depr(3y)77.81%
Cap/Depr(5y)87.04%
Cap/Sales(3y)7.8%
Cap/Sales(5y)8.15%
Profit Quality(3y)205.64%
Profit Quality(5y)166.63%
High Growth Momentum
Growth
EPS 1Y (TTM)12.73%
EPS 3Y-8.95%
EPS 5Y-3.09%
EPS Q2Q%6.78%
EPS Next Y8.32%
EPS Next 2Y11.81%
EPS Next 3Y13.96%
EPS Next 5Y16.11%
Revenue 1Y (TTM)4.96%
Revenue growth 3Y2.82%
Revenue growth 5Y6.05%
Sales Q2Q%4.3%
Revenue Next Year4.69%
Revenue Next 2Y5.62%
Revenue Next 3Y5.95%
Revenue Next 5Y7.47%
EBIT growth 1Y-4.65%
EBIT growth 3Y-8.54%
EBIT growth 5Y-4.97%
EBIT Next Year81.37%
EBIT Next 3Y28.68%
EBIT Next 5Y24.78%
FCF growth 1Y9.1%
FCF growth 3Y21.91%
FCF growth 5Y-0.13%
OCF growth 1Y6.07%
OCF growth 3Y7.18%
OCF growth 5Y2.72%
EUROFINS SCIENTIFIC / ESF0.DE Fundamental Analysis FAQ
What is the ChartMill fundamental rating of EUROFINS SCIENTIFIC (ESF0.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to ESF0.DE.
What is the valuation status for ESF0 stock?
ChartMill assigns a valuation rating of 5 / 10 to EUROFINS SCIENTIFIC (ESF0.DE). This can be considered as Fairly Valued.
What is the profitability of ESF0 stock?
EUROFINS SCIENTIFIC (ESF0.DE) has a profitability rating of 4 / 10.
What are the PE and PB ratios of EUROFINS SCIENTIFIC (ESF0.DE) stock?
The Price/Earnings (PE) ratio for EUROFINS SCIENTIFIC (ESF0.DE) is 16.53 and the Price/Book (PB) ratio is 2.47.
How sustainable is the dividend of EUROFINS SCIENTIFIC (ESF0.DE) stock?
The dividend rating of EUROFINS SCIENTIFIC (ESF0.DE) is 6 / 10 and the dividend payout ratio is 26.8%.